Healthequity (HQY) Receives a Buy from KeyBanc

By Austin Angelo

KeyBanc analyst Donald Hooker reiterated a Buy rating on Healthequity (HQYResearch Report) today and set a price target of $77.00. The company’s shares closed last Monday at $61.24.

According to, Hooker is ranked #473 out of 5715 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Healthequity with a $76.50 average price target, a 24.3% upside from current levels. In a report issued on December 2, Barrington also reiterated a Buy rating on the stock with a $75.00 price target.

See today’s analyst top recommended stocks >>

Based on Healthequity’s latest earnings release for the quarter ending October 31, the company reported a quarterly GAAP net loss of $21.33 million. In comparison, last year the company had a net profit of $15.69 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health planbs, brokers, consultants and financial advisors.